1. Cost Analysis of the Addition of Hyperacute Magnetic Resonance Imaging for Selection of Patients for Endovascular Stroke Therapy
- Author
-
Shumei Man, Nancy A. Obuchowski, Gábor Tóth, Seby John, Nancy Papesh, Zeshaun Khawaja, Dan Tomic, Ken Uchino, Muhammad S Hussain, Dolora Wisco, Terry Lesko, Michael T. Modic, Esteban Cheng-Ching, Nicolas R. Thompson, Thomas J. Masaryk, and Paul Ruggieri
- Subjects
medicine.medical_specialty ,Original Paper ,medicine.diagnostic_test ,business.industry ,Confounding ,Magnetic resonance imaging ,medicine.disease ,Confidence interval ,03 medical and health sciences ,Indirect costs ,0302 clinical medicine ,medicine ,Cost analysis ,Surgery ,030212 general & internal medicine ,Neurology (clinical) ,Radiology ,Cardiology and Cardiovascular Medicine ,business ,Stroke ,030217 neurology & neurosurgery ,Selection (genetic algorithm) ,Computed tomography angiography - Abstract
Background and Purpose: Patient selection is important to determine the best candidates for endovascular stroke therapy. In application of a hyperacute magnetic resonance imaging (MRI) protocol for patient selection, we have shown decreased utilization with improved outcomes. A cost analysis comparing the pre- and post-MRI protocol time periods was performed to determine if the previous findings translated into cost opportunities. Materials and Methods: We retrospectively identified individuals considered for endovascular stroke therapy from January 2008 to August 2012 who were ≤8 h from stroke symptoms onset. Patients prior to April 30, 2010 were selected based on results of the computed tomography/computed tomography angiography alone (pre-hyperacute), whereas patients after April 30, 2010 were selected based on results of MRI (post-hyperacute MRI). Demographic, outcome, and financial information was collected. Log-transformed average daily direct costs were regressed on time period. The regression model included demographic and clinical covariates as potential confounders. Multiple imputation was used to account for missing data. Results: We identified 267 patients in our database (88 patients in pre-hyperacute MRI period, 179 in hyperacute MRI protocol period). Patient length of stay was not significantly different in the hyperacute MRI protocol period as compared to the pre-hyperacute MRI period (10.6 vs. 9.9 days, p < 0.42). The median of average daily direct costs was reduced by 24.5% (95% confidence interval 14.1-33.7%, p < 0.001). Conclusions: Use of the hyperacute MRI protocol translated into reduced costs, in addition to reduced utilization and better outcomes. MRI selection of patients is an effective strategy, both for patients and hospital systems.
- Published
- 2017